Eprenetapopt (APR-246) and Azacitidine in TP53 -Mutant Myelodysplastic Syndromes
Sallman, David A, DeZern, Amy E, Garcia-Manero, Guillermo, Steensma, David P, Roboz, Gail J, Sekeres, Mikkael A, Cluzeau, Thomas, Sweet, Kendra L, McLemore, Amy, McGraw, Kathy L, Puskas, John, Zhang, Ling, Yao, Jiqiang, Mo, Qianxing, Nardelli, Lisa, Al Ali, Najla H, Padron, Eric, Korbel, Greg, Attar, Eyal C, Kantarjian, Hagop M, Lancet, Jeffrey E, Fenaux, Pierre, List, Alan F, Komrokji, Rami S
Published in Journal of clinical oncology (10.05.2021)
Published in Journal of clinical oncology (10.05.2021)
Get full text
Journal Article
Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study
Gillis, Nancy K, PharmD, Ball, Markus, PhD, Zhang, Qing, MD, Ma, Zhenjun, PhD, Zhao, YuLong, PhD, Yoder, Sean J, MS, Balasis, Maria E, BS, Mesa, Tania E, BS, Sallman, David A, MD, Lancet, Jeffrey E, Prof, Komrokji, Rami S, Prof, List, Alan F, Prof, McLeod, Howard L, Prof, Alsina, Melissa, Prof, Baz, Rachid, MD, Shain, Kenneth H, MD, Rollison, Dana E, PhD, Padron, Eric, Dr
Published in The lancet oncology (01.01.2017)
Published in The lancet oncology (01.01.2017)
Get full text
Journal Article
Applying Synthetic Lethality for the Selective Targeting of Cancer
McLornan, Donal P, List, Alan, Mufti, Ghulam J
Published in The New England journal of medicine (30.10.2014)
Published in The New England journal of medicine (30.10.2014)
Get full text
Journal Article
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults
Savona, Michael R., Malcovati, Luca, Komrokji, Rami, Tiu, Ramon V., Mughal, Tariq I., Orazi, Attilio, Kiladjian, Jean-Jacques, Padron, Eric, Solary, Eric, Tibes, Raoul, Itzykson, Raphael, Cazzola, Mario, Mesa, Ruben, Maciejewski, Jaroslaw, Fenaux, Pierre, Garcia-Manero, Guillermo, Gerds, Aaron, Sanz, Guillermo, Niemeyer, Charlotte M., Cervantes, Francisco, Germing, Ulrich, Cross, Nicholas C.P., List, Alan F.
Published in Blood (19.03.2015)
Published in Blood (19.03.2015)
Get full text
Journal Article
TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype
Sallman, David A., McLemore, Amy F., Aldrich, Amy L., Komrokji, Rami S., McGraw, Kathy L., Dhawan, Abhishek, Geyer, Susan, Hou, Hsin-An, Eksioglu, Erika A., Sullivan, Amy, Warren, Sarah, MacBeth, Kyle J., Meggendorfer, Manja, Haferlach, Torsten, Boettcher, Steffen, Ebert, Benjamin L., Al Ali, Najla H., Lancet, Jeffrey E., Cleveland, John L., Padron, Eric, List, Alan F.
Published in Blood (10.12.2020)
Published in Blood (10.12.2020)
Get full text
Journal Article
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype
Basiorka, Ashley A., McGraw, Kathy L., Eksioglu, Erika A., Chen, Xianghong, Johnson, Joseph, Zhang, Ling, Zhang, Qing, Irvine, Brittany A., Cluzeau, Thomas, Sallman, David A., Padron, Eric, Komrokji, Rami, Sokol, Lubomir, Coll, Rebecca C., Robertson, Avril A.B., Cooper, Matthew A., Cleveland, John L., O'Neill, Luke A., Wei, Sheng, List, Alan F.
Published in Blood (22.12.2016)
Published in Blood (22.12.2016)
Get full text
Journal Article
Biological drivers of clinical phenotype in myelofibrosis
Mascarenhas, John, Gleitz, Hélène F. E., Chifotides, Helen T., Harrison, Claire N., Verstovsek, Srdan, Vannucchi, Alessandro Maria, Rampal, Raajit K., Kiladjian, Jean-Jacques, Vainchenker, William, Hoffman, Ronald, Schneider, Rebekka K., List, Alan F.
Published in Leukemia (01.02.2023)
Published in Leukemia (01.02.2023)
Get full text
Journal Article
Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117
Sekeres, Mikkael A, Othus, Megan, List, Alan F, Odenike, Olatoyosi, Stone, Richard M, Gore, Steven D, Litzow, Mark R, Buckstein, Rena, Fang, Min, Roulston, Diane, Bloomfield, Clara D, Moseley, Anna, Nazha, Aziz, Zhang, Yanming, Velasco, Mario R, Gaur, Rakesh, Atallah, Ehab, Attar, Eyal C, Cook, Elina K, Cull, Alyssa H, Rauh, Michael J, Appelbaum, Frederick R, Erba, Harry P
Published in Journal of clinical oncology (20.08.2017)
Published in Journal of clinical oncology (20.08.2017)
Get full text
Journal Article
Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
FENAUX, Pierre, MUFTI, Ghulam J, DOMBRET, Hervé, BACKSTROM, Jay, ZIMMERMAN, Linda, MCKENZIE, David, BEACH, C. L, SILVERMAN, Lewis R, HELLSTROM-LINDBERG, Eva, SANTINI, Valeria, GATTERMANN, Norbert, GERMING, Ulrich, SANZ, Guillermo, LIST, Alan F, GORE, Steven, SEYMOUR, John F
Published in Journal of clinical oncology (01.02.2010)
Published in Journal of clinical oncology (01.02.2010)
Get full text
Journal Article
Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs
Rollison, Dana E., Howlader, Nadia, Smith, Martyn T., Strom, Sara S., Merritt, William D., Ries, Lynn A., Edwards, Brenda K., List, Alan F.
Published in Blood (01.07.2008)
Published in Blood (01.07.2008)
Get full text
Journal Article
Deferasirox Reduces Serum Ferritin and Labile Plasma Iron in RBC Transfusion–Dependent Patients With Myelodysplastic Syndrome
List, Alan F, Baer, Maria R, Steensma, David P, Raza, Azra, Esposito, Jason, Martinez-Lopez, Noelia, Paley, Carole, Feigert, John, Besa, Emmanuel
Published in Journal of clinical oncology (10.06.2012)
Published in Journal of clinical oncology (10.06.2012)
Get full text
Journal Article
A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial
Gore, Steven D, Fenaux, Pierre, Santini, Valeria, Bennett, John M, Silverman, Lewis R, Seymour, John F, Hellström-Lindberg, Eva, Swern, Arlene S, Beach, Charles L, List, Alan F
Published in Haematologica (Roma) (01.07.2013)
Published in Haematologica (Roma) (01.07.2013)
Get full text
Journal Article
First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
FELDMAN, Eric J, LANCET, Jeffrey E, LOUIE, Arthur C, KOLITZ, Jonathan E, RITCHIE, Ellen K, ROBOZ, Gail J, LIST, Alan F, ALLEN, Steven L, ASATIANI, Ekatherine, MAYER, Lawrence D, SWENSON, Christine
Published in Journal of clinical oncology (10.03.2011)
Published in Journal of clinical oncology (10.03.2011)
Get full text
Journal Article
Phase 1 study of lenzilumab, a recombinant anti–human GM-CSF antibody, for chronic myelomonocytic leukemia
Patnaik, Mrinal M., Sallman, David A., Mangaonkar, Abhishek A., Heuer, Rachel, Hirvela, Jeffery, Zblewski, Darci, Al-Kali, Aref, Binder, Moritz, Balasis, Maria E., Newman, Hannah, Letson, Christopher, Kruer, Traci L., Gangat, Naseema, Komrokji, Rami S., Tefferi, Ayalew, Lo, Adrian, Shih, Ted, Durrant, Cameron, List, Alan F., Padron, Eric
Published in Blood (13.08.2020)
Published in Blood (13.08.2020)
Get full text
Journal Article
Monocyte subset analysis accurately distinguishes CMML from MDS and is associated with a favorable MDS prognosis
Talati, Chetasi, Zhang, Ling, Shaheen, Ghada, Kuykendall, Andrew, Ball, Markus, Zhang, Qing, Lancet, Jeffrey E., Zuckerman, Kenneth S., List, Alan F., Komrokji, Rami, Moscinski, Lynn, Padron, Eric
Published in Blood (30.03.2017)
Published in Blood (30.03.2017)
Get full text
Journal Article
Induction of myelodysplasia by myeloid-derived suppressor cells
Chen, Xianghong, Eksioglu, Erika A, Zhou, Junmin, Zhang, Ling, Djeu, Julie, Fortenbery, Nicole, Epling-Burnette, Pearlie, Van Bijnen, Sandra, Dolstra, Harry, Cannon, John, Youn, Je-in, Donatelli, Sarah S, Qin, Dahui, De Witte, Theo, Tao, Jianguo, Wang, Huaquan, Cheng, Pingyan, Gabrilovich, Dmitry I, List, Alan, Wei, Sheng
Published in The Journal of clinical investigation (01.11.2013)
Published in The Journal of clinical investigation (01.11.2013)
Get full text
Journal Article